» Articles » PMID: 37242645

A Versatile Brij-Linker for One-Step Preparation of Targeted Nanoparticles

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2023 May 27
PMID 37242645
Authors
Affiliations
Soon will be listed here.
Abstract

: Most frequently the functionalization of nanoparticles is hampered by time-consuming, sometimes harsh conjugation and purification procedures causing premature drug release and/or degradation. A strategy to circumvent multi-step protocols is to synthesize building blocks with different functionalities and to use mixtures thereof for nanoparticle preparation in one step. : BrijS20 was converted into an amine derivative via a carbamate linkage. The Brij-amine readily reacts with pre-activated carboxyl-containing ligands such as folic acid. The structures of the building blocks were confirmed by different spectroscopic methods and their utility was assessed by one-step preparation and characterization of nanoparticles applying PLGA as a matrix polymer. : Nanoparticles were about 200 nm in diameter independent of the composition. Experiments with human folate expressing single cells and monolayer revealed that the nanoparticle building block Brij mediates a "stealth" effect and the Brij-amine-folate a "targeting" effect. As compared to plain nanoparticles, the stealth effect decreased the cell interaction by 13%, but the targeting effect increased the cell interaction by 45% in the monolayer. Moreover, the targeting ligand density and thus the cell association of the nanoparticles is easily fine-tuned by selection of the initial ratio of the building blocks. : This strategy might be a first step towards the one-step preparation of nanoparticles with tailored functionalities. Relying on a non-ionic surfactant is a versatile approach as it might be extended to other hydrophobic matrix polymers and promising targeting ligands from the biotech pipeline.

Citing Articles

Nanocomposite alginate hydrogel loaded with propranolol hydrochloride kolliphor based cerosomes as a repurposed platform for Methicillin-Resistant Staphylococcus aureus-(MRSA)-induced skin infection; in-vitro, ex-vivo, in-silico, and in-vivo....

Eltabeeb M, Hamed R, El-Nabarawi M, Teaima M, A Hamed M, Darwish K Drug Deliv Transl Res. 2024; 15(2):556-576.

PMID: 38762697 PMC: 11683024. DOI: 10.1007/s13346-024-01611-z.


Revolutionizing Psoriasis Topical Treatment: Enhanced Efficacy Through Ceramide/Phospholipid Composite Cerosomes Co-Delivery of Cyclosporine and Dithranol: In-Vitro, Ex-Vivo, and in-Vivo Studies.

Elhabal S, Abdelaal N, Al-Zuhairy S, Elrefai M, Khalifa M, Khasawneh M Int J Nanomedicine. 2024; 19:1163-1187.

PMID: 38344440 PMC: 10859058. DOI: 10.2147/IJN.S443812.


Improving Cancer Targeting: A Study on the Effect of Dual-Ligand Density on Targeting of Cells Having Differential Expression of Target Biomarkers.

Sultana N, David A Int J Mol Sci. 2023; 24(17).

PMID: 37685852 PMC: 10487485. DOI: 10.3390/ijms241713048.

References
1.
Xiong W, Sang W, Linghu K, Zhong Z, Cheang W, Li J . Dual-functional Brij-S20-modified nanocrystal formulation enhances the intestinal transport and oral bioavailability of berberine. Int J Nanomedicine. 2018; 13:3781-3793. PMC: 6030940. DOI: 10.2147/IJN.S163763. View

2.
Fredenberg S, Wahlgren M, Reslow M, Axelsson A . The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems--a review. Int J Pharm. 2011; 415(1-2):34-52. DOI: 10.1016/j.ijpharm.2011.05.049. View

3.
Miyazawa K, Takayama M . Multiple Hydrogen Loss from [M + H] and [a] ions of Peptides in MALDI In-Source Decay Using a Dinitro-Substituted Matrix. J Am Soc Mass Spectrom. 2020; 31(3):547-552. DOI: 10.1021/jasms.9b00013. View

4.
Robin B, Albert C, Beladjine M, Legrand F, Geiger S, Moine L . Tuning morphology of Pickering emulsions stabilised by biodegradable PLGA nanoparticles: How PLGA characteristics influence emulsion properties. J Colloid Interface Sci. 2021; 595:202-211. DOI: 10.1016/j.jcis.2021.03.061. View

5.
Fam S, Chee C, Yong C, Ho K, Mariatulqabtiah A, Tan W . Stealth Coating of Nanoparticles in Drug-Delivery Systems. Nanomaterials (Basel). 2020; 10(4). PMC: 7221919. DOI: 10.3390/nano10040787. View